Dreieich, Germany

Thomas Haeder

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 11.8

ph-index = 3

Forward Citations = 17(Granted Patents)


Location History:

  • Dreieichenhain, DE (2016)
  • Dreieich, DE (2016 - 2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Inventions of Thomas Haeder

Introduction

Thomas Haeder, an accomplished inventor based in Dreieich, Germany, has made significant contributions to the field of medicine through his innovative patents. With three registered patents, his work primarily focuses on immunoconjugates targeting CD138, showcasing his expertise in developing methods that aim to treat diseases associated with specific cellular targets.

Latest Patents

Among his latest patents, Thomas Haeder has disclosed a method and composition for treating diseases involving target cells expressing CD138. This method involves administering an immunoconjugate that includes an engineered targeting antibody aimed at CD138 expressing cells along with an effector molecule, following a multiple dose regimen. The regimen consists of at least two doses, structured to exceed the maximum tolerable dose (MTD) when administered as a single dose. This innovative approach is focused on maximizing treatment efficacy while minimizing toxicity to patients. Additionally, he has developed immunoconjugates that demonstrate specific targeting for CD138 expressed on target cells, highlighting their homogenous targeting capabilities.

Career Highlights

Throughout his career, Thomas Haeder has been associated with notable companies within the biotechnology sector, including Biotest AG and Immunogen, Inc. These affiliations have provided him with a platform to apply his inventive ideas and collaborate with other industry leaders in developing groundbreaking therapies.

Collaborations

Thomas has had the privilege of collaborating with esteemed colleagues such as Gregor Schulz and Frank Osterroth. These partnerships have undoubtedly contributed to his success, fostering an environment of innovation and knowledge sharing that has advanced their collective research in immunotherapeutics.

Conclusion

Thomas Haeder's work embodies the spirit of innovation within the biotechnology field. His patents not only reflect his expertise and dedication to improving patient outcomes but also highlight the potential impact of targeted therapies in treating complex diseases. As he continues to develop new immunoconjugates and methods, the medical community eagerly anticipates the advancements that his inventions may bring.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…